{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:34:47Z","timestamp":1764858887605},"reference-count":48,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec><jats:label \/><jats:p>To estimate the prevalence of diagnosed and undiagnosed coinfections among HIV, HBV, and HCV infected patients. Retrospective analysis of laboratory records for HIV, HBV, and HCV patients presenting at the HIV outpatient clinic. Serological data including hepatitis B surface antigen (HBsAg), hepatitis B e\u2010antigen (HBeAg), hepatitis B e\u2010antibody (anti\u2010HBe), antibodies to HIV and HCV, anti\u2010toxoplasmosis IgG and IgM antibodies, and anti\u2010syphilis antibodies (VDRL) were collected. We obtained data for 628 (218 HCV, 268 HBV, and 142 HIV) patients. Male\u2010to\u2010female ratios were 1:1 for HCV, 3:4 for HBV, and 5:3 for HIV. Age means (SD) were 54.24 (16.40), 44.53 (18.83), and 40.39 (15.92) years for HCV, HBV, and HIV, respectively. In HIV group, the prevalence of HBV and HCV coinfections was 8.5% and 2.8%, respectively. In HBV group, the prevalence of HCV and HIV coinfections was 1.1% and 1.5%, respectively. In HCV group, HIV or HBV coinfections occurred at the same frequency (1.4%). An absence of screening for coinfections was detected in 7.0\u201348.5% patients as per the group and the infectious agent; which represents an estimated proportion of 20 out of 1,000 patients with an undiagnosed coinfection. Despite a relatively low prevalence of coinfections, a significant proportion of cases remain undiagnosed because of a lack of systematic screening. <jats:bold><jats:italic>J. Med. Virol. 88:1545\u20131551, 2016<\/jats:italic><\/jats:bold>. \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.24503","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T19:56:42Z","timestamp":1455998202000},"page":"1545-1551","source":"Crossref","is-referenced-by-count":9,"title":["Co\u2010infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia"],"prefix":"10.1002","volume":"88","author":[{"given":"Jamil A.","family":"Al\u2010Mughales","sequence":"first","affiliation":[{"name":"Division of Diagnostic Immunology, Department of Clinical Laboratory Medicine King Abdulaziz University Hospital Jeddah Saudi Arabia"},{"name":"Faculty of Medicine, Department of Medical Microbiology and Immunology King Abdulaziz University Jeddah Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.103425"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000386729.56683.33"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009011"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1737.114303"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2014.207"},{"key":"e_1_2_7_7_1","first-page":"1559","article-title":"Human immunodeficiency virus in Saudi Arabia","volume":"25","author":"Alrajhi AA","year":"2004","journal-title":"Saudi Med J"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.004"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69374-4"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.06.013"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2516(96)89656-7"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i40.14559"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-013-0533-x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(11)60020-9"},{"key":"e_1_2_7_15_1","first-page":"26","article-title":"Prevalence of HBV, HCV, HIV\u20101, 2 and HTLV\u2010I\/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia","volume":"25","author":"El\u2010Hazmi MM","year":"2004","journal-title":"Saudi Med J"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i42.6879"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000192090.61753.d4"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70135-4"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.02.023"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000163936.99401.fe"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106899"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02976.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i11.2955"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-3"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.51500"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.05.018"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045919"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-8-416"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"e_1_2_7_30_1","first-page":"1158","article-title":"Toxoplasmosis in HIV\/AIDS patients: A living legacy","volume":"40","author":"Nissapatorn V","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/1119-3077.151790"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31872-1"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i1.121"},{"key":"e_1_2_7_34_1","first-page":"226","article-title":"Clinical characteristics of hepatitis B and C virus infections in HIV\u2010infected patients","volume":"98","author":"Phuangchoei P","year":"2015","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu476"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200309011-00009"},{"key":"e_1_2_7_37_1","first-page":"1","article-title":"Syphilis and HIV co\u2010infection: Excellent response to multiple doses of benzathine penicillin","volume":"23","author":"Saje A","year":"2014","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007410707801"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i37.5015"},{"key":"e_1_2_7_40_1","first-page":"S6","article-title":"Viral hepatitis and HIV co\u2010infection","volume":"44","author":"Soriano V","year":"2010","journal-title":"Antiviral Res"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.10.021"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/313842"},{"key":"e_1_2_7_43_1","first-page":"1349","article-title":"Prevalence of hepatitis B virus and hepatitis C virus co\u2010infection with human immunodefi ciency virus in Thai patients: A tertiary\u2010care\u2010based study","volume":"87","author":"Sungkanuparph S","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-28032013000400007"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis367"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00222.x"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v4.i2.96"},{"key":"e_1_2_7_48_1","unstructured":"World Health Organization.2012. Guidance on prevention of viral hepatitis B and C among people who inject drugs."},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/474S12a"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24503","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.24503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:16:56Z","timestamp":1694722616000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1002\/jmv.24503"],"URL":"https:\/\/doi.org\/10.1002\/jmv.24503","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}